Search

Author/Creator Engert, A.

1. EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ADVANCED‐STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL. (June 2017)

Authors:
Borchmann, P.; Goergen, H.; Kobe, C.; Eichenauer, D.; Greil, R.; Lohri, A.; Novak, U.; Markova, J.; Beck, H.; Meissner, J.; Zijlstra, J.M.; Ostermann, H.; Feuring‐Buske, M.; Dierlamm, J.; Eich, H.; Baues, C.; Rosenwald, A.; Fuchs, M.; Diehl, V.; Kuhnert, G.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. NIVOLUMAB FOR RELAPSED OR REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL) AFTER AUTOLOGOUS TRANSPLANTATION: 5‐YEAR OVERALL SURVIVAL FROM THE PHASE 2 CHECKMATE 205 STUDY. (17th June 2021)

Authors:
Ansell, S. M.; Bröckelmann, P. J.; von Keudell, G.; Lee, H. J.; Santoro, A.; Zinzani, P. L.; Collins, G. P.; Cohen, J. B.; De Boer, J. P.; Kuruvilla, J.; Savage, K. J.; Trneny, M.; Provencio, M.; Jaeger, U.; Willenbacher, W.; Swanink, R.; Sacchi, M.; Shipp, M. A.; Engert, A.; Armand, P.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW‐UP OF THE PHASE 2 CHECKMATE 205 TRIAL. (June 2017)

Authors:
Fanale, M.; Engert, A.; Younes, A.; Armand, P.; Ansell, S.; Zinzani, P.L.; Timmerman, J.M.; Collins, G.P.; Ramchandren, R.; Cohen, J.B.; De Boer, J.P.; Kuruvilla, J.; Savage, K.J.; Trneny, M.; Rodig, S.; Shipp, M.; Kato, K.; Sumbul, A.; Farsaci, B.; Santoro, A.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
135
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. S203: ABSCOPAL EFFECT OF RADIOTHERAPY AND NIVOLUMAB IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: PRE-PLANNED INTERIM ANALYSIS OF THE INTERNATIONAL GHSG PHASE II AERN TRIAL. (23rd June 2022)

Authors:
Bröckelmann, P.; Bühnen, I.; Zijlstra, J.; Fossa, A.; Meissner, J.; Mathas, S.; Rosenbrock, J.; Kobe, C.; Fuchs, M.; Plütschow, A.; Marnitz, S.; Borchmann, P.; Engert, A.; Baues, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
104
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗